Research Papers:

Sevoflurane preconditioning ameliorates traumatic spinal cord injury through caveolin-3-dependent cyclooxygenase-2 inhibition

Weidong Wu _, Ningxian Wei, Lihui Wang, Danhui Kong, Gang Shao, Yingchun Qin, Lixin Wang and Yansheng Du

PDF  |  HTML  |  How to cite

Oncotarget. 2017; 8:87658-87666. https://doi.org/10.18632/oncotarget.21142

Metrics: PDF 1319 views  |   HTML 2082 views  |   ?  


Weidong Wu1,*, Ningxian Wei1,*, Lihui Wang1,*, Danhui Kong1, Gang Shao1, Yingchun Qin1, Lixin Wang2 and Yansheng Du3

1Danyang People’s Hospital of Jiangsu Province, Danyang, Jiangsu, PR China

2School of Medicine, Southeast University, Nanjing, Jiangsu, PR China

3School of Medicine, Indiana University, Indianapolis, Indiana, United States

*These authors have contributed equally to this work

Correspondence to:

Weidong Wu, email: [email protected]

Keywords: sevoflurane preconditioning, traumatic spinal cord injury, COX-2, Cav-3, anaesthesia

Received: March 21, 2017     Accepted: August 26, 2017     Published: September 21, 2017


Acute traumatic spinal cord injury (tSCI) results in a lifetime of paralysis associated with a host of medical complications. The developing secondary complications of tSCI may result in further chronic neurodegenerative diseases. Sevoflurane preconditioning (SF-PreCon) has shown guaranteed protective effects in myocardial or cerebral ischemic/reperfusion injury. However, the role of SF-PreCon in tSCI still remains to be elucidated. Here, we found that SF-PreCon ameliorated the developing secondary complications through reducing the apoptosis rate and the secretion of inflammatory cytokines in injured spinal cord tissues, and therefore enhancing the recovery after tSCI. Notably, we demonstrated that SF-PreCon ameliorates tSCI through inhibiting Cycloxygenase-2 (COX-2). Importantly, we verified that SF-PreCon inhibits the expression of COX-2 and reduces the apoptosis rate after tSCI via the induction of Caveolin-3 (Cav-3). Taken together, our results suggest that SF-PreCon ameliorates tSCI via Cav-3-dependent COX-2 inhibition and provide an economical and practical method against the secondary injury after tSCI.

Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 21142